Isolation of human NK cells by density gradient centrifugation.
about
vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cellsA human immunoglobulin G receptor exists in both polypeptide-anchored and phosphatidylinositol-glycan-anchored formsMitogen and lymphokine stimulation of heat shock proteins in T lymphocytes.Physical association between the CD8 and HLA class I molecules on the surface of activated human T lymphocytes.Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging.Phenotypic and functional characterization of lymphocytes that bind human microvascular endothelial cells in vitro. Evidence for preferential binding of natural killer cells.Natural killer cells are present in the normal human lung but are functionally impotent.Phospholipid methylation and phospholipase A2 activation in cytotoxicity by human natural killer cells.Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins.Mechanism of cytotoxicity of human large granular lymphocytes: relationship of the cytotoxic lymphocyte protein to the ninth component (C9) of human complement.Human natural killing against ovarian carcinoma.Effect of a streptococcal preparation (OK432) on natural killer activity of tumour-associated lymphoid cells in human ovarian carcinoma and on lysis of fresh ovarian tumour cells.Inhibition of in vitro natural killer activity by the third component of complement: role for the C3a fragmentCharacteristics of human large granular lymphocytes and relationship to natural killer and K cellsPossible role for C-reactive protein in the human natural killer cell responseLymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.Accessory cell function of human B cells. I. Production of both interleukin 1-like activity and an interleukin 1 inhibitory factor by an EBV-transformed human B cell lineAugmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver.T cell receptor beta chain gene rearrangements in lymphoproliferative disorders of large granular lymphocytes/natural killer cells.Lymphokine-activated killer cells. Analysis of progenitors and effectors.Antibacterial activity of human natural killer cellsStudies of lymphokine-activated killer (LAK) cells. I. Evidence using novel monoclonal antibodies that most human LAK precursor cells share a common surface marker.Model for studying virus attachment: identification and quantitation of Epstein-Barr virus-binding cells by using biotinylated virus in flow cytometryMycobacterial induction of activated killer cells: possible role of tyrosine kinase activity in interleukin-2 receptor alpha expression.Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages.Suppression of natural killing in vitro by monocytes and polymorphonuclear leukocytes: requirement for reactive metabolites of oxygen.Natural killer (HNK-1+) cells in Chediak-Higashi patients are present in normal numbers but are abnormal in function and morphology.Inhibition of human natural killer cell activity by Pseudomonas aeruginosa alkaline protease and elastaseStreptococcus pneumoniae cocultured with fibroblasts enhances both interferon production and cytotoxic activity by lymphocytes.Molecular and functional characterization of canine interferon-epsilon.Arylsulfatase in natural killer cells: its possible role in cytotoxicity.The natural killer cell: a further innate mediator of gouty inflammation?Murine monoclonal antibodies to the myelin-associated glycoprotein react with large granular lymphocytes of human blood.Human natural killer cells, activated lymphocyte killer cells, and monocytes possess similar cytotoxic mechanisms.An overview of the potential strategies for NK cell-based immunotherapy for acute myeloid leukemia.Listeria monocytogenes activation of human peripheral blood lymphocytes: induction of non-major histocompatibility complex-restricted cytotoxic activity and cytokine production.Production of granulocyte-macrophage colony-stimulating factor (GM-CSF) by monocytes and large granular lymphocytes stimulated with Mycobacterium avium-M. intracellulare: activation of bactericidal activity by GM-CSF.Potentiation of human natural killer cell cytotoxicity by Salmonella bacteria is an interferon- and interleukin-2-independent process that utilizes CD2 and CD18 structures in the effector phase.Human T helper cells specific for antigens of typhus group rickettsiae enhance natural killer cell activity in vitro.Heterogeneous activity of immature and mature cells of the murine monocyte-macrophage lineage derived from different anatomical districts against yeast-phase Candida albicans.
P2860
Q24296261-0593AAFF-9692-46D6-B641-8B6957A7F839Q24612040-8E595DBE-C545-4CF5-B015-C7102D7CEFFFQ33577604-BB251DBC-96DF-4D8F-9C39-49D01586E4A5Q33578567-75EA793C-51CC-43E0-A447-162D9E26507BQ33901974-26A8F99B-6D89-49D6-AD23-4A662343E84BQ34575567-812ACB14-2766-42C5-A06F-5B181C8D4979Q34614312-EB192E96-4A86-48D7-AA96-045C90F34762Q35386258-C6DCCB6C-DFE8-4250-AE6E-D41F65BD5C7EQ35605061-9B5D17EC-72C0-431B-824F-544750D4D8B8Q35617486-EF34EC53-8659-4441-BC8C-19B0CC835F9CQ36047756-61278A1F-EF20-4617-9BCC-BA7C229CECCBQ36048180-06C725A3-CA6C-4F29-B02B-FB9EDFDE8936Q36314546-5ABE9B5E-3E9F-4DBA-BB51-76A4288959EBQ36344555-12A92F66-A415-40FB-8EBC-15113140252EQ36347311-2328DD73-2E11-4ADD-BFDC-991B8B46BB3AQ36347625-31EBBBB4-73B6-4F53-AD1D-81B4F0384B3BQ36348847-2B36C11D-E38D-4D24-B2C7-AD70E91C0356Q36349612-E38C89DA-0D35-4497-84EA-E709B8B75EA3Q36351370-404D5575-8D5C-4C99-B248-854C3982963CQ36352956-A4910037-71E8-473B-B1EF-944B83A82DFCQ36355907-C52437DD-BBC6-4FE1-9E82-293952609A31Q36356148-30A7486B-9C39-4E05-8BBC-256E049F5E97Q36872003-5F73DADA-CDD3-4C3B-B079-2DD375723CF8Q36947724-9DDD5079-4905-4A44-AD53-18D14849F730Q36958690-E2FA7946-76AE-4277-9017-24BE8334B277Q36982442-9BF1734F-2B6C-4CF1-9515-6E52DCDFC24FQ36985526-8C75F560-C982-4871-AC19-91789C8F2D4BQ37017904-122EF8BE-1E7F-4EDC-8719-221CCD51B6C3Q37032864-CD15FCAD-C445-4ACC-9641-4425D7ECF186Q37404040-14630F9F-1386-44C8-9FF8-B523E103F62AQ37512182-A324AB90-C851-41FA-AD99-1BE91AECADB7Q37638179-1658DCBA-0153-4577-9F0C-DE6FBAA223A3Q37675667-64F0986B-EA86-4370-8B7C-6606A36C8CC6Q37690860-40BD6485-C713-4BC3-9DC8-508E4B88B145Q38930242-68D5BA7A-E75D-4A11-917B-B3C198C96242Q40146475-BBF18397-ACE4-401A-8118-8D8E88CCF89BQ40151083-AEDBC3AA-7D97-4DCE-B21C-AF42D844840AQ40151408-025EE29A-8704-430F-8439-4248CCA75C70Q40161645-FEBFE920-EC9B-4DD0-97C5-8F5D09F6B8ACQ40161769-2EF31AE9-0883-4C46-B656-1937AB703197
P2860
Isolation of human NK cells by density gradient centrifugation.
description
1980 nî lūn-bûn
@nan
1980 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1980 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
name
Isolation of human NK cells by density gradient centrifugation.
@ast
Isolation of human NK cells by density gradient centrifugation.
@en
Isolation of human NK cells by density gradient centrifugation.
@nl
type
label
Isolation of human NK cells by density gradient centrifugation.
@ast
Isolation of human NK cells by density gradient centrifugation.
@en
Isolation of human NK cells by density gradient centrifugation.
@nl
prefLabel
Isolation of human NK cells by density gradient centrifugation.
@ast
Isolation of human NK cells by density gradient centrifugation.
@en
Isolation of human NK cells by density gradient centrifugation.
@nl
P1476
Isolation of human NK cells by density gradient centrifugation.
@en
P2093
P304
P356
10.1016/0022-1759(80)90133-7
P577
1980-01-01T00:00:00Z